Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study
Article in Vaccines (January 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Vaccines (January 2024)
Article in PLOS Global Public Health (September 2023)
Article in PLOS ONE (September 2023)